GT Biopharma to Host Interim GTB-3550 TriKE™ Data Review Call with Dr. Jeffrey S. Miller on May 19, 2021 at 4:00 PM ETPennyStocks • 05/18/21
GT Biopharma to Host Interim GTB-3550 TriKE™ Data Review Call with Dr. Jeffrey S. Miller on May 19, 2021 at 4:00 PM ET.PRNewsWire • 05/18/21
OXIS International Inc. (GTBP) Gains As Market Dips: What You Should KnowZacks Investment Research • 05/17/21
GT Biopharma Announces Update On The Commencement Of The GTB-3550 TriKE™ Monotherapy Phase 2 Clinical Trial And Solid Tumor TriKE™ Product Candidates.PennyStocks • 05/12/21
GT Biopharma Announces Update On The Commencement Of The GTB-3550 TriKE™ Monotherapy Phase 2 Clinical Trial And Solid Tumor TriKE™ Product CandidatesPRNewsWire • 05/12/21
GT Biopharma Announces the Appointments of Gregory Berk, M.D. to Chief Medical Officer and Jeffrey S. Miller, M.D. to Consulting Chief Scientific OfficerPennyStocks • 04/26/21
GT Biopharma Announces the Appointments of Gregory Berk, M.D. to Chief Medical Officer and Jeffrey S.PRNewsWire • 04/26/21
OXIS International Inc. (GTBP) Gains But Lags Market: What You Should KnowZacks Investment Research • 04/21/21
GT Biopharma Reports Fourth Quarter and Year End 2020 Results and Business UpdatePRNewsWire • 04/19/21
GT Biopharma Announces GTB-3550 TriKE™ Monotherapy Rescues and Restores NK Cell Immune Surveillance in Relapsed/Refractory AML and MDS Cancer PatientsPRNewsWire • 04/12/21
GT Biopharma Announces Enrollment Of Patient 10 in GTB-3550 TriKE™ Phase I/II Clinical TrialPRNewsWire • 04/08/21